Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis

Journal of Neuroimaging

Volumn 19, Issue 1, 2009, Pages 3-8

  Neema, Mohit ^a   Arora, Ashish ^a   Healy, Brian C ^a   Guss, Zachary D ^a   Brass, Steven D ^a   Duan, Yang ^b   Buckle, Guy J ^a   Glanz, Bonnie I ^a   Stazzone, Lynn ^a   Khoury, Samia J ^a   Weiner, Howard L ^a   Guttmann, Charles R G ^a,b   Bakshi, Rohit ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Brain atrophy; Iron; MRI; Multiple sclerosis; Neurologic disability; T2 hyperintense lesions; T2 hypointensity

Indexed keywords

ADULT; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN DAMAGE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISABILITY; DISEASE COURSE; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PUTAMEN; THALAMUS;

ADULT; AREA UNDER CURVE; BRAIN; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; HUMANS; IRON; LOGISTIC MODELS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES;

EID: 58149347604     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2008.00296.x     Document Type: Article

References (32)

1. Bakshi R, Thompson AJ, Rocca MA, et al. MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 2008;7:615-625.
2. Brex PA, Ciccarelli O, O'Riordan JI, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158-164.
3. Fisher E, Rudick RA, Simon JH, et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002;59:1412-1420.
4. Zivadinov R, Leist TP. Clinical-MRI correlations in multiple sclerosis. J Neuroimaging 2005;15:10S-21S.
5. Neema M, Stankiewicz J, Arora A, et al. MRI in multiple sclerosis: what's inside the toolbox? Neurotherapeutics 2007;4:602-617.
6. Pirko I, Lucchinetti CF, Sriram S, et al. Gray matter involvement in multiple sclerosis. Neurology 2007;68:634-642.
7. Bakshi R, Dmochowski J, Shaikh ZA, et al. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 2001;185:19-26.
8. Tjoa CW, Benedict RH, Weinstock-Guttman B, et al. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci 2005;234:17-24.
9. Brass SD, Benedict RH, Weinstock-Guttman B, et al. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006;12:437-444.
10. Zhang Y, Zabad RK, Wei X, et al. Deep grey matter "blackT2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler 2007;13:880-883.
11. Ge Y, Jensen JH, Lu H, et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007;28:1639-1644.
12. Hammond KE, Metcalf M, Okuda DT, et al. In vivo high resolution MR imaging at 7T of multiple sclerosis with sensitivity to iron. Neurology 2008;70:A8.
13. Bermel RA, Puli SR, Rudick RA, et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 2005;62:1371-1376.
14. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
15. Gauthier SA, Glanz BI, Mandel M, et al. A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study. Autoimmun Rev 2006;5:532-536.
16. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-846.
17. Wei X, Warfield S, Zou KH, et al. Quantitative analysis of MRI signal abnormalities of brain whitematter with high reproducibility and accuracy. J Magn Reson Imaging 2002;15:203-209.
18. Pelletier D, Garrison K, Henry R. Measurement of whole-brain atrophy in multiple sclerosis. J Neuroimaging 2004;14:11S-19S.
19. Bakshi R, Benedict RH, Bermel RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002;59:62-68.
20. Stankiewicz J, Panter SS, Neema M, et al. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 2007;4:371-386.
21. Smith MA, Castellani R, Napoli S, et al. Gray matter iron deposition in patients with multiple sclerosis: a histochemical study. Neurology 2007;68:A118.
22. Craelius W, Migdal WM, Lussenhop CP, et al. Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982;106:397-399.
23. Pedchenko TV, LeVine S. Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. J Neuroimmunol 1998;84:188-197.
24. Forge JK, Pedchenko TV, LeVine SM. Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. Life Sci 1998;63:2271-2284.
25. Levine SM, Chakrabarty A. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann NY Acad Sci 2004;1012:252-266.
26. Grant SM, Wiesinger JA, Beard JL, et al. Iron-deficient mice fail to develop autoimmune encephalomyelitis. J Nutr 2003;3:2635-2638.
27. Mitchell KM, Dotson AL, Cool KM, et al. Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis. Mult Scler 2007;13:1118-1126.
28. Schipper HM. Heme oxygemase-1: Transducer of pathological brain iron sequestration under oxidative stress. Ann NY Acad Sci 2004;1012:84-93.
29. Neema M, Stankiewicz J, Arora A, et al. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging 2007;17:16S-21S.
30. Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006;5:158-170.
31. Gauthier SA, Mandel M, Guttmann CR, et al. Predicting short-term disability in multiple sclerosis. Neurology 2007;68:2059-2065.
32. Losseff NA, Wang L, Lai HM, et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 1996;119:2009-2019.